Cder-2023-118707 delivery of human blood donor for bioassay development, under solicitation FDA-RFQ-cder-2023-118707.

Ended Purchase Order Awarded Last action

Contract number
75F40123P00230
Awardee
Awarding agency
Obligated
$51,218

Award facts

Opportunity
Contract value 100% obligated
$51,218.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621991 Blood and Organ Banks
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Folsom, CA 95630, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$5,266
Original award $56,484

About this award

Written by GovTribe AI ·

The Food and Drug Administration awarded a purchase order to Stemexpress, LLC for $51,218.00 on September 15, 2023, under total small business set-aside solicitation FDA-RFQ-CDER-2023-118707. The order calls for delivery of human blood donor specimens for bioassay development. Performance occurs in Folsom, California, with ultimate completion on March 29, 2024. Stemexpress is a small disadvantaged woman-owned business. The solicitation was posted April 11, 2023, with a due date of April 25, 2023.

Quick answers

Who was awarded contract 75F40123P00230?

75F40123P00230 was awarded to Stemexpress, LLC by Food and Drug Administration (Department of Health and Human Services) on September 15, 2023.

How much is contract 75F40123P00230 worth?

The government has obligated $51,218 on 75F40123P00230.

Was contract 75F40123P00230 competed?

The extent of competition for 75F40123P00230 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login